InvestorsHub Logo

GoClippers

04/24/16 8:47 PM

#124620 RE: Inoviorulez #124619

He never saw that the CEO would switch to ESS???

ESS is Rubenfeld's baby, not Gerald's. Rubenfeld was on the board of Regenicin. He is the one pushing ESS.


Because when Rubenfield signed on board he thought the company would advance MANF, Lympro, Eltoprazine. He never saw that the CEO would switch to ESS. First of all ESS is a dermatolgoy indication what does that have to do with Neurology? Parkinson's, Alzheimer's, etc.